Effectiveness and safety of bivalirudin in elderly patients with coronary artery disease undergoing percutaneous coronary intervention: A real‐world study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effectiveness and safety of bivalirudin in elderly patients with coronary artery disease undergoing percutaneous coronary intervention: A real‐world study
Authors
Keywords
-
Journal
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-01-26
DOI
10.1002/ccd.30099
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
- (2020) Jean-Philippe Collet et al. EUROPEAN HEART JOURNAL
- Predicting long-term ischemic events using routine clinical parameters in patients with coronary artery disease: The OPT-CAD risk score
- (2018) Yaling Han et al. Cardiovascular Therapeutics
- 2018 ESC/EACTS Guidelines on myocardial revascularization
- (2018) Franz-Josef Neumann et al. EUROPEAN HEART JOURNAL
- Fourth Universal Definition of Myocardial Infarction (2018)
- (2018) Kristian Thygesen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Bivalirudin versus heparin in patients undergoing percutaneous peripheral interventions: A systematic review and meta-analysis
- (2018) Wilman Olmedo et al. Vascular
- 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
- (2017) Borja Ibanez et al. EUROPEAN HEART JOURNAL
- Bivalirudin versus Heparin Monotherapy in Myocardial Infarction
- (2017) David Erlinge et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcomes of ≤6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation
- (2016) Pedro A. Villablanca et al. MEDICINE
- Bivalirudin vs Heparin With or Without Tirofiban During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction
- (2015) Yaling Han et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes
- (2015) Marco Valgimigli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial
- (2014) Adeel Shahzad et al. LANCET
- Bivalirudin Started during Emergency Transport for Primary PCI
- (2013) Philippe Gabriel Steg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age, treatment, and outcomes in high-risk non‐ST-segment elevation acute coronary syndrome patients: Insights from the EARLY ACS trial
- (2012) Renato D. Lopes et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Advanced Age, Antithrombotic Strategy, and Bleeding in Non–ST-Segment Elevation Acute Coronary Syndromes
- (2009) Renato D. Lopes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Bivalirudin during Primary PCI in Acute Myocardial Infarction
- (2008) Gregg W. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started